Day One Biopharmaceuticals Holding Company, LLC
395 Oyster Point Blvd., Suite 217
South San Francisco, CA 94080
May 24, 2021
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Day One Biopharmaceuticals Holding Company, LLC Registration Statement on Form S-1 (File No. 333-255754) originally filed May 4, 2021, as amended, and corresponding Registration Statement on Form 8-A (File No. 001-40431) filed May 24, 2021
Requested Date: May 26, 2021
Requested Time: 4:30 PM Eastern Time
Ladies and Gentlemen:
Day One Biopharmaceuticals Holding Company, LLC (the Registrant) hereby requests that the Securities and Exchange Commission take appropriate action to declare the above-captioned Registration Statements on Form S-1 and Form 8-A effective at the Requested Date and Requested Time set forth above or as soon thereafter as practicable.
The Registrant hereby authorizes Robert A. Freedman or Julia Forbess, both of whom are attorneys with the Registrants outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Freedman at (650) 335-7292 or, in his absence, Ms. Forbess at (415) 875-2420.
* * *
|DAY ONE BIOPHARMACEUTICALS HOLDING COMPANY, LLC|
|By:||/s/ Jeremy Bender, Ph.D., M.B.A.|
|Jeremy Bender, Ph.D., M.B.A.|
|Chief Executive Officer|
Robert A. Freedman, Esq.
Effie Toshav, Esq.
Julia Forbess, Esq.
Fenwick & West LLP
[Signature Page to Company Acceleration Request Letter]